Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonviva Extension Study in Postmenopausal Osteoporosis
NCT00545090Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, open-label, single-arm trial of ibandronic acid in postmenopausal osteoporosis, sponsored by Roche. Primary endpoints: Serious Adverse Events, Adverse Events and 4 more. Started Aug 2006; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00545090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545090.